The five-year survival rate for Stage I or Stage II lung cancer is now more than 65%, compared to just 8% for later-Stages III and IV of the disease, according to the American Lung Association. The news was welcomed by Montefiore Einstein Comprehensive Cancer Center (MECCC) officials who said their clinicians are now finding cancers when they are most treatable and curable thanks to enhanced screening, novel care, access to clinical trials, and community education.